Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Institutional National Research Service Award (T32)
Project #
5T32CA075930-03
Application #
6150304
Study Section
Subcommittee G - Education (NCI)
Program Officer
Eckstein, David J
Project Start
1998-02-24
Project End
2003-01-31
Budget Start
2000-03-13
Budget End
2001-01-31
Support Year
3
Fiscal Year
2000
Total Cost
$124,000
Indirect Cost

  Institution

Name
University of Alabama Birmingham
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
004514360
City
Birmingham
State
AL
Country
United States
Zip Code
35294

  Publications

Alberti, M O; Deshane, J S; Chaplin, D D et al. (2013) A myeloid cell-binding adenovirus efficiently targets gene transfer to the lung and escapes liver tropism. Gene Ther 20:733-41
Cody, James J; Rivera, Angel A; Lyons, Gray R et al. (2013) Expression of osteoprotegerin from a replicating adenovirus inhibits the progression of prostate cancer bone metastases in a murine model. Lab Invest 93:268-78
Alberti, Michael O; Roth, Justin C; Ismail, Mourad et al. (2012) Derivation of a myeloid cell-binding adenovirus for gene therapy of inflammation. PLoS One 7:e37812
Yang, Sherry W; Chanda, Diptiman; Cody, James J et al. (2011) Conditionally replicating adenovirus expressing TIMP2 increases survival in a mouse model of disseminated ovarian cancer. PLoS One 6:e25131
Wang, Wei; Rayburn, Elizabeth R; Velu, Sadanandan E et al. (2010) A novel synthetic iminoquinone, BA-TPQ, as an anti-breast cancer agent: in vitro and in vivo activity and mechanisms of action. Breast Cancer Res Treat 123:321-31
Cody, J J; Rivera, A A; Lyons, G R et al. (2010) Arming a replicating adenovirus with osteoprotegerin reduces the tumor burden in a murine model of osteolytic bone metastases of breast cancer. Cancer Gene Ther 17:893-905
Wang, Feng; Ezell, Scharri J; Zhang, Yong et al. (2010) FBA-TPQ, a novel marine-derived compound as experimental therapy for prostate cancer. Invest New Drugs 28:234-41
Gamble, Lena J; Borovjagin, Anton V; Matthews, Qiana L (2010) Role of RGD-containing ligands in targeting cellular integrins: Applications for ovarian cancer virotherapy (Review). Exp Ther Med 1:233-240
Matthews, Kellie; Noker, Patricia E; Tian, Baohong et al. (2009) Identifying the safety profile of Ad5.SSTR/TK.RGD, a novel infectivity-enhanced bicistronic adenovirus, in anticipation of a phase I clinical trial in patients with recurrent ovarian cancer. Clin Cancer Res 15:4131-7
Cody, J J; Douglas, J T (2009) Armed replicating adenoviruses for cancer virotherapy. Cancer Gene Ther 16:473-88

Showing the most recent 10 out of 42 publications